Ani Pharmaceuticals's major customers
1 listed supplier reports Ani Pharmaceuticals as a customer worth 10% or more of their revenue, led by EyePoint at 55%.
Get an email when Ani Pharmaceuticals's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Major customers of Ani Pharmaceuticals
Customers that Ani Pharmaceuticals named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.
Formerly disclosed
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Cardinal HealthCAH | 23% | last FY 2019 | 1 year | FY 2019 · filed 15 Mar 2022 |
Suppliers that depend on Ani Pharmaceuticals
Listed companies whose annual report names Ani Pharmaceuticals as a customer worth 10% or more of their revenue. If Ani Pharmaceuticals cuts orders or switches supplier, these are the companies that feel it.
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| EyePointEYPT | 55% | ▼ from 94% | 3 years | FY 2025 · filed 5 Mar 2026 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API